These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35736504)

  • 1. SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila.
    Dunham KE; Venton BJ
    J Neurochem; 2022 Sep; 162(5):404-416. PubMed ID: 35736504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors.
    Dunham KE; Khaled KH; Weizman L; Venton BJ
    J Neurochem; 2024 Jun; 168(6):1097-1112. PubMed ID: 38323657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.
    Nichols AL; Blumenfeld Z; Luebbert L; Knox HJ; Muthusamy AK; Marvin JS; Kim CH; Grant SN; Walton DP; Cohen BN; Hammar R; Looger L; Artursson P; Dougherty DA; Lester HA
    J Neurosci; 2023 Mar; 43(13):2222-2241. PubMed ID: 36868853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microdosing ketamine in
    Dunham KE; Khaled KH; Weizman L; Venton BJ
    bioRxiv; 2023 Nov; ():. PubMed ID: 37986873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
    Thériault O; Poulin H; Beaulieu JM; Chahine M
    Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacogenetics of the selective serotonin reuptake inhibitors.
    Brøsen K
    Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
    Sanchez C; Reines EH; Montgomery SA
    Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
    Maurel S; De Vry J; Schreiber R
    Alcohol; 1999 Apr; 17(3):195-201. PubMed ID: 10231167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
    Shih YC; Bekele NB; Xu Y
    Pharmacoeconomics; 2007; 25(10):843-62. PubMed ID: 17887806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice.
    Amada N; Hirose T; Suzuki M; Kakumoto Y; Futamura T; Maeda K; Kikuchi T
    Neuropsychopharmacol Rep; 2023 Mar; 43(1):132-136. PubMed ID: 36649966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
    van Harten J
    Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
    Cryan JF; O'Leary OF; Jin SH; Friedland JC; Ouyang M; Hirsch BR; Page ME; Dalvi A; Thomas SA; Lucki I
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8186-91. PubMed ID: 15148402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats.
    Oosting RS; Chan JS; Olivier B; Banerjee P; Choi YK; Tarazi F
    Psychopharmacology (Berl); 2016 Mar; 233(6):1025-34. PubMed ID: 26758283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of serotonin reuptake inhibitors fluoxetine and escitalopram on bone markers and microarchitecture in Wistar rats.
    Kumar M; Wadhwa R; Kothari P; Trivedi R; Vohora D
    Eur J Pharmacol; 2018 Apr; 825():57-62. PubMed ID: 29470959
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Gao YL; He B
    DNA Cell Biol; 2018 Dec; 37(12):1055-1060. PubMed ID: 30256659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.